Canine Cushing’s Disease
Canine Cushing’s Disease
This category covers Canine Cushing’s Disease, a hormone disorder caused by excess cortisol, with US shipping from Canada available for eligible items, and it gathers medications, monitoring tools, and learning resources so you can compare brands, forms, strengths, and handling requirements before selecting a product suited to veterinary directions.
Shoppers use it to review treatment options like trilostane, mitotane, selegiline, and ketoconazole, understand common testing workflows and follow-up schedules, and assess supportive care such as diet adjustments, skin care, and joint support for dogs that may experience fatigue, thirst changes, skin infections, or muscle weakness over time.
Inventory and package sizes can change by batch, supplier, or season, so availability, strength counts, and labeling may vary across listings, and listings might include equivalent brand or generic presentations, without implying that every item, concentration, or flavor is in stock at all times or accessible in every jurisdiction.
What’s in This Category
This section highlights prescription therapies, supportive products, and reference information related to dogs with cortisol excess, also called canine hyperadrenocorticism. Primary drug classes include adrenal enzyme blockers, adrenal cytotoxics, dopamine agonists, and antifungals used for hormonal modulation. Items are typically tablets or capsules with weight-based dosing, sometimes in multiple strengths to simplify titration and maintenance.
Content also touches on monitoring topics, such as follow-up testing intervals, expected response timelines, and adverse event recognition. Typical audiences include owners managing confirmed pituitary-dependent disease, dogs with adrenal tumors, and senior patients needing careful dose adjustments. You can compare labeled strengths, capsule counts, and handling or disposal notes, with neutral background on why a veterinarian might escalate or de-escalate therapy over time.
How to Choose for Canine Cushing’s Disease
Selection starts after diagnostic confirmation, usually by ACTH stimulation testing in dogs or low-dose dexamethasone suppression testing for dogs. Consider the disease subtype, concurrent conditions, and the veterinarian’s targeted control level. Review labeled strengths that match prescribed doses, since splitting capsules is generally not recommended. Check any hepatic, renal, or adrenal cautions and plan early rechecks to fine-tune therapy.
Storage and handling are straightforward for most products, typically at controlled room temperature and protected from moisture. Some agents warrant cautious handling and careful disposal. Avoid abrupt changes without veterinary guidance, and document observed behavior, appetite, and thirst between checks to support dosing decisions.
- Common mistake: starting before confirmation of subtype and baseline labs.
- Common mistake: changing dose without scheduled monitoring or clinical notes.
- Common mistake: ignoring drug–drug interactions or food administration guidance.
Popular Options
Vetoryl capsules contain trilostane, an adrenal enzyme blocker used to reduce cortisol synthesis. Many veterinarians consider trilostane for dogs the first-line choice for pituitary-dependent disease. Doses are individualized, often with morning administration and early rechecks to balance control with safety.
Lysodren (mitotane) is used to selectively destroy adrenal cortex tissue during induction, then maintain at a lower frequency. It suits specific cases where cytotoxic adrenal control is required and close monitoring is feasible. Handling care and consistent follow-ups help manage risks and maintain stable outcomes.
Anipryl (selegiline) may be considered in selected pituitary-driven cases, where dopaminergic mechanisms are relevant and mild clinical signs are present. Response rates can vary, so documentation and scheduled evaluations matter. For some dogs, ketoconazole is discussed as an alternative when other options are not tolerated or have contraindications.
Related Conditions & Uses
Clinicians distinguish pituitary-driven and adrenal-driven disease because management steps differ. Pituitary-dependent cases often respond to enzyme blockade regimens with careful retesting, while adrenal tumor cases sometimes require oncology or surgical consultation. Practical follow-up includes dog cortisol testing during stabilization, then at intervals to assess control and clinical progress.
Associated concerns can include hypertension, urinary tract infections, skin infections, and insulin resistance. Care teams may watch body weight, liver enzyme trends, and electrolyte status. Diet changes can focus on balanced nutrition and skin health, though nutrition alone does not correct hormonal excess. Notes on exercise tolerance and mobility can help track subtle improvements after dose adjustments.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.
Authoritative Sources
These resources provide reference overviews relevant to veterinary endocrinology for dogs.
- Overview from Merck Veterinary Manual on canine hyperadrenocorticism: Merck Veterinary Manual – Hyperadrenocorticism in Dogs.
- Manufacturer information on trilostane capsule indications and monitoring: Dechra – Vetoryl Capsules.
- Regulatory drug information for approved veterinary trilostane products: FDA – Animal Drugs @ FDA.
Filter
Product price
Product categories
Conditions
Select options
This product has multiple variants. The options may be chosen on the product page
Frequently Asked Questions
Do these medications require a prescription?
Yes, most Cushing’s therapies for dogs are prescription-only. A veterinarian confirms the diagnosis, selects a starting dose, and schedules retesting. Pharmacies typically verify prescription details before dispensing. Stock, labeling, and refill limits can vary by jurisdiction. Browsing different strengths is possible, but dispensing follows the written veterinary order.
How do I choose the right strength or capsule count?
Follow the exact veterinary prescription. Strength selection reflects weight-based dosing, response, and monitoring plans. Capsules are generally not split, so strengths should align with the prescribed dose. Capsule counts depend on dosing frequency and recheck timing. Review product pages for labeled storage and any handling precautions noted for specific agents.
What monitoring is typical after starting therapy?
Veterinarians often recheck within the first two to three weeks, then adjust as needed. Follow-up can include clinical notes and lab work, such as stimulation or suppression testing. Frequency depends on response, adverse effects, and disease subtype. Stable dogs transition to less frequent checks, with periodic reassessment to confirm continued control.
Are there special storage or handling considerations?
Most items store at controlled room temperature and away from moisture. Some agents require careful handling and disposal due to their pharmacologic effects. Keep original packaging and follow label directions. Avoid accidental exposure to children or other pets. Review each listing’s specific handling notes, since labeling can differ by manufacturer.
Can diet or supplements manage Cushing’s by themselves?
Diet or supplements do not correct excess cortisol production. Balanced nutrition and targeted skin or joint support may help overall comfort during treatment. Any supplement should be discussed with the veterinary team to avoid interactions. Medication choice and dosing remain central, guided by diagnostic confirmation and scheduled monitoring.
Related Articles
Diabetes, Type 1
Insulin Overdose: Signs, Symptoms, Risks, and Care Guide
Key TakeawaysInsulin Overdose can quickly drive blood glucose too low, which threatens brain function and heart rhythm. Recognizing early neuroglycopenic and adrenergic signs helps prevent complications. This guide outlines causes,…